capsicum
Capsicum annuum is a flowering plant in the family Solanaceae (nightshades), native to the northern regions of South America and to southwestern North America. The plant produces berries of many colors including red, green, and yellow, often with pungent taste. It is one of the oldest cultivated crops, with domestication dating back to around 6,000 years ago in regions of Mexico. The genus Capsicum has over 30 species but Capsicum annuum is the primary species in its genus, as it has been widely cultivated for human consumption for a substantial amount of time and has spread across the world. This species has many uses in culinary applications, medicine, self defense, and can even be ornamental. — Wikipedia
Clinical trial activity
7 trials · 14 clinical orgs · 0 marketing orgs
Earliest trial started Apr 1, 2008 (NCT00692601)
Timeline
Indications
Approved for
Mechanism of action
- Unspecified targetUnclear
unclear
Chemistry & pharmacology
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- WikipediaCapsicum annuum ↗
- NCATSUW86K581WY ↗
- ChEMBLCHEMBL2108237 ↗
- WikipediaCapsicum ↗
Also known as
- capsiate natura
- capsiate natura
- capsicum annuum
- capsicum frutescens fruits
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04025346 | N/A | Jul 12, 2019 | Vedic Lifesciences Pvt. Ltd. |
| NCT04125563 | Phase 2 | Jun 1, 2019 | University of Gothenburg, Vastra Gotaland Region, Vinnova |
| NCT04874701 | Phase 4 | Jan 7, 2018 | Laval University, OmniActive Health Technologies |
| NCT03489226 | N/A | May 2, 2016 | OmniActive Health Technologies, Pennington Biomedical Research Center |
| NCT01315041 | Phase 1/Phase 2 (Phase 2) | Dec 1, 2014 | Casa Espirita Terra de Ismael, University of Ribeirao Preto, University of Sao Paulo |
| NCT02345447 | Phase 3 | Oct 1, 2013 | University of Tuebingen |
| NCT00692601 | Phase 1 | Apr 1, 2008 | Ajinomoto, Hamilton Health Sciences Corporation, McMaster University |
Organizations
Research & Development (14)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| OmniActive Health Technologies | For profit | 2 | 0 | 2 | 2016 |
| Ajinomoto | For profit | 1 | 0 | 1 | 2008 |
| Casa Espirita Terra de Ismael | Academic/Hospital | 1 | 1 | 1 | 2014 |
| Hamilton Health Sciences Corporation | Academic/Hospital | 1 | 1 | 1 | 2008 |
| Laval University | Academic/Hospital | 1 | 1 | 1 | 2018 |
| McMaster University | Academic/Hospital | 1 | 0 | 1 | 2008 |
| Pennington Biomedical Research Center | Academic/Hospital | 1 | 1 | 1 | 2016 |
| University of Gothenburg | Academic/Hospital | 1 | 0 | 1 | 2019 |
| University of Ribeirao Preto | Academic/Hospital | 1 | 0 | 1 | 2014 |
| University of Sao Paulo | Academic/Hospital | 1 | 0 | 1 | 2014 |
| University of Tuebingen | Academic/Hospital | 1 | 1 | 1 | 2013 |
| Vastra Gotaland Region | Government | 1 | 1 | 1 | 2019 |
| Vedic Lifesciences Pvt. Ltd. | For profit | 1 | 1 | 1 | 2019 |
| Vinnova | Government | 1 | 0 | 1 | 2019 |